Human menopausal gonadotrophins in the treatment of unexplained infertility.
Ninety one patients with unexplained infertility were treated with human menopausal gonadotrophin (HMG) and human chorionic gonadotrophin (HCG). The overall pregnancy rates were 29% per patient and 11% per cycle. In patients under the age of 37, the rates were 40% per patient and 15% per cycle. Many cycles (15%) were cancelled because of poor response to stimulation and by definition these women had normal cycles prior to stimulation. Within 1 year of ceasing HMG treatment, 9 patients had conceived spontaneously and another 4 conceived by GIFT.
Hughes
G J
GJ
School of Obstetrics and Gynaecology, University of New South Wales, Sydney.
Garrett
D K
DK
Lowy
M
M
D000328:Adult; D000367:Age Factors; D006063:Chorionic Gonadotropin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy*; D008596:Menotropins / Q000627:therapeutic use*; D011247:Pregnancy; D013997:Time Factors; D016896:Treatment Outcome
D006063:Chorionic Gonadotropin; D008596:Menotropins